Voloridge Investment Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-150,930
| Closed | -$820K | – | 1664 |
|
|
2022
Q4 | $820K | Sell |
150,930
-177,870
| -54% | -$966K | ﹤0.01% | 1175 |
|
|
2022
Q3 | $4.11M | Buy |
+328,800
| New | +$4.11M | 0.02% | 714 |
|
|
2022
Q1 | – | Sell |
-33,859
| Closed | -$346K | – | 1772 |
|
|
2021
Q4 | $346K | Sell |
33,859
-208,094
| -86% | -$2.13M | ﹤0.01% | 1457 |
|
|
2021
Q3 | $3.25M | Sell |
241,953
-105,171
| -30% | -$1.41M | 0.02% | 858 |
|
|
2021
Q2 | $7.62M | Buy |
347,124
+3,758
| +1% | +$82.5K | 0.05% | 492 |
|
|
2021
Q1 | $8.26M | Buy |
343,366
+84,589
| +33% | +$2.04M | 0.06% | 396 |
|
|
2020
Q4 | $4.66M | Buy |
258,777
+239,423
| +1,237% | +$4.31M | 0.04% | 478 |
|
|
2020
Q3 | $224K | Buy |
+19,354
| New | +$224K | ﹤0.01% | 1183 |
|
|
2020
Q2 | – | Sell |
-18,943
| Closed | -$209K | – | 1562 |
|
|
2020
Q1 | $209K | Buy |
+18,943
| New | +$209K | 0.01% | 940 |
|
|
2019
Q2 | – | Sell |
-25,366
| Closed | -$421K | – | 1145 |
|
|
2019
Q1 | $421K | Buy |
+25,366
| New | +$421K | 0.01% | 714 |
|